Perspective Therapeutics (CATX) Change in Acquisitions & Divestments (2016 - 2026)

Perspective Therapeutics' Change in Acquisitions & Divestments history spans 10 years, with the latest figure at $47.6 million for Q1 2026.

  • On a quarterly basis, Change in Acquisitions & Divestments rose 119.5% to $47.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $25.9 million, a 74.18% decrease, with the full-year FY2024 number at $78.7 million, up 245.85% from a year prior.
  • Change in Acquisitions & Divestments hit $47.6 million in Q1 2026 for Perspective Therapeutics, up from -$119.7 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for CATX hit a ceiling of $49.8 million in Q2 2025 and a floor of -$119.7 million in Q4 2025.
  • Historically, Change in Acquisitions & Divestments has averaged $18.0 million across 5 years, with a median of $38.2 million in 2024.
  • Biggest five-year swings in Change in Acquisitions & Divestments: crashed 395.45% in 2025 and later skyrocketed 119.5% in 2026.
  • Tracing CATX's Change in Acquisitions & Divestments over 5 years: stood at $12.5 million in 2022, then surged by 81.56% to $22.8 million in 2023, then surged by 77.93% to $40.5 million in 2024, then crashed by 395.45% to -$119.7 million in 2025, then skyrocketed by 139.81% to $47.6 million in 2026.
  • Business Quant data shows Change in Acquisitions & Divestments for CATX at $47.6 million in Q1 2026, -$119.7 million in Q4 2025, and $48.2 million in Q3 2025.